Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,533 | -$13,072 | -$854 | -$138 |
| Dep. & Amort. | $4,339 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,867 | $0 | $0 | $0 |
| Change in WC | $126 | $114 | $385 | $19 |
| Other Non-Cash | $130 | $9,098 | $0 | $0 |
| Operating Cash Flow | -$5,070 | -$3,860 | -$469 | -$119 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$101 | $3,170 | $462 | $0 |
| Stock Issued | $6,833 | $1,000 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$397 | -$310 | $8 | $119 |
| Financing Cash Flow | $6,335 | $3,860 | $470 | $119 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,265 | -$0 | $1 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $1 | $0 | $0 |
| End Cash | $1,266 | $1 | $1 | $0 |
| Free Cash Flow | -$5,070 | -$3,860 | -$469 | -$119 |